Literature DB >> 24591015

Toward development of interleukin-11 as a medical countermeasure for use in radiological/nuclear emergencies.

Martin Hauer-Jensen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24591015      PMCID： PMC4071113          DOI： 10.1007/s10620-014-3074-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  8 in total

1.  The protective role of interleukin-11 against neutron radiation injury in mouse intestines via MEK/ERK and PI3K/Akt dependent pathways.

Authors:  Leilei Yang; Ruijuan Wang; Yabing Gao; Xinping Xu; Kaifei Fu; Shaoxia Wang; Yang Li; Ruiyun Peng
Journal:  Dig Dis Sci       Date:  2014-01-23       Impact factor: 3.199

Review 2.  Literature review and global consensus on management of acute radiation syndrome affecting nonhematopoietic organ systems.

Authors:  Nicholas Dainiak; Robert Nicolas Gent; Zhanat Carr; Rita Schneider; Judith Bader; Elena Buglova; Nelson Chao; C Norman Coleman; Arnold Ganser; Claude Gorin; Martin Hauer-Jensen; L Andrew Huff; Patricia Lillis-Hearne; Kazuhiko Maekawa; Jeffrey Nemhauser; Ray Powles; Holger Schünemann; Alla Shapiro; Leif Stenke; Nelson Valverde; David Weinstock; Douglas White; Joseph Albanese; Viktor Meineke
Journal:  Disaster Med Public Health Prep       Date:  2011-10-10       Impact factor: 1.385

3.  Microcolony survival assay for cells of mouse intestinal mucosa exposed to radiation.

Authors:  H R Withers; M M Elkind
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1970

4.  Transcriptional regulation of the interleukin-11 gene by oncogenic Ras.

Authors:  Soon Young Shin; Chan Choi; Hong Ghi Lee; Yoongho Lim; Young Han Lee
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

5.  Oral interleukin 11 as a countermeasure to lethal total-body irradiation in a murine model.

Authors:  Alexander F Burnett; Prabath G Biju; Huanli Lui; Martin Hauer-Jensen
Journal:  Radiat Res       Date:  2013-11-12       Impact factor: 2.841

6.  Protection of the small intestinal clonogenic stem cells from radiation-induced damage by pretreatment with interleukin 11 also increases murine survival time.

Authors:  C S Potten
Journal:  Stem Cells       Date:  1996-07       Impact factor: 6.277

7.  Citrulline: a physiologic marker enabling quantitation and monitoring of epithelial radiation-induced small bowel damage.

Authors:  Ludy C H W Lutgens; Nicolaas E P Deutz; John Gueulette; Jack P M Cleutjens; Martijn P F Berger; Bradly G Wouters; Maarten F von Meyenfeldt; Philippe Lambin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2003-11-15       Impact factor: 7.038

8.  Interleukin-11 protects the clonogenic stem cells in murine small-intestinal crypts from impairment of their reproductive capacity by radiation.

Authors:  C S Potten
Journal:  Int J Cancer       Date:  1995-07-28       Impact factor: 7.396
  8 in total
  4 in total

1.  PEGylated IL-11 (BBT-059): A Novel Radiation Countermeasure for Hematopoietic Acute Radiation Syndrome.

Authors:  Vidya P Kumar; Shukla Biswas; Neel K Sharma; Sasha Stone; Christine M Fam; George N Cox; Sanchita P Ghosh
Journal:  Health Phys       Date:  2018-07       Impact factor: 1.316

2.  Delayed effects of acute whole body lethal radiation exposure in mice pre-treated with BBT-059.

Authors:  Neel K Sharma; Gregory P Holmes-Hampton; Vidya P Kumar; Shukla Biswas; Kefale Wuddie; Sasha Stone; Zemenu Aschenake; William L Wilkins; Christine M Fam; George N Cox; Sanchita P Ghosh
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379

Review 3.  Repurposing Pharmaceuticals Previously Approved by Regulatory Agencies to Medically Counter Injuries Arising Either Early or Late Following Radiation Exposure.

Authors:  Vijay K Singh; Thomas M Seed
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

4.  CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.

Authors:  Merriline Satyamitra; Lynnette Cary; Dylan Dunn; Gregory P Holmes-Hampton; Lawrence J Thomas; Sanchita P Ghosh
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.